Business Combinations (Details) - Schedule of Pro Forma Results Effects of ICU Eyewear Acquisition - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Pro Forma Results Effects of ICU Eyewear Acquisition [Line Items]
Revenues	$ 70,711,483	$ 69,375,505
Net loss	(32,595,728)	(11,806,564)
Net loss attributable to common shareholders	$ (33,903,916)	$ (21,076,180)
Loss per share attributable to common shareholders:
Basic (in Dollars per share)	$ (92.8)	$ (878.14)